![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1250, 2000-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL effect of HRT in postmenopausal women
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HRT solely for prevention of CHD in postmenopausal women
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL effect of raloxifene, HRT in postmenopausal women
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HRT use "unjustified" among asymptomatic women
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HRT use may not increase the incidence of breast cancer in Japanese women
Reactions Weekly, Vol. 1, Iss. 1084, 2006-01 ,pp. :